I saw it had great support in the .30's
I sat in for 2 weeks on it's run up to test the 200EMA and watch it get rejected so I got out.
2 weeks later it makes a few HH's and then the 3X Pop. but i missed it.
It was ok to get out at the 200 EMA rejection on Dec 10th. Actually the right thing to do.
But then I took my eyes off the trade and failed to see the rise at the end of December, figuring that I already dipped my toes in once and didn't want to do it again.
I get that way with stocks sometimes. If I've already hopped out once and hop back in again then I feel like I'm admitting I was wrong for hopping out the first time.
I need to remember it's ok to jump back in if you got out 2 weeks ago. Take the trade set ups for what they are, don't develop any bias toward the trade from past experiences.
I've been having a hard time evaluating Therapeutic stocks. SYN has research trials for products related to gastrointestinal (GI) diseases which I have no idea about.
My approach to medical stocks needs to definitely sharpen up, for right now all I'm doing is spotting good chart set ups and making sure they have some fundamental potential.
Would love any advise from how others approach these Bio Medical stocks
I sat in for 2 weeks on it's run up to test the 200EMA and watch it get rejected so I got out.
2 weeks later it makes a few HH's and then the 3X Pop. but i missed it.
It was ok to get out at the 200 EMA rejection on Dec 10th. Actually the right thing to do.
But then I took my eyes off the trade and failed to see the rise at the end of December, figuring that I already dipped my toes in once and didn't want to do it again.
I get that way with stocks sometimes. If I've already hopped out once and hop back in again then I feel like I'm admitting I was wrong for hopping out the first time.
I need to remember it's ok to jump back in if you got out 2 weeks ago. Take the trade set ups for what they are, don't develop any bias toward the trade from past experiences.
I've been having a hard time evaluating Therapeutic stocks. SYN has research trials for products related to gastrointestinal (GI) diseases which I have no idea about.
My approach to medical stocks needs to definitely sharpen up, for right now all I'm doing is spotting good chart set ups and making sure they have some fundamental potential.
Would love any advise from how others approach these Bio Medical stocks